Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
However, researchers saw little difference across racial groups in HBV treatment initiation among those who were eligible.
Generic drugs are cheaper and lead to better treatment compliance compared with brand-name drugs.
Most people who stopped long-term nucleoside/nucleotide analogs did not need to restart treatment.
Even without HBV immunoglobulin, no infants acquired hepatitis B from mothers with a high viral load.
The antiviral treatment is safe and effective for pediatric patients ages 12 and up.
The Hepatitis B Foundation and Rx Outreach will supply two frontline medications: tenofovir and entecavir. Here’s how to enroll.
Previous studies of the association between tenofovir and COVID-19 outcomes in people with HIV have yielded mixed results.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
Two different studies found that Vemlidy was safe and effective for pregnant women and their infants.
Chinese researchers studied 81 women with chronic hepatitis B who began taking Viread before pregnancy.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.
Nevertheless, researchers advise careful kidney monitoring when pairing the medications.
A recent study analyzed kidney parameters among those with HIV who were treated for hep C with the regimen.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.